HighTower Advisors LLC reduced its holdings in shares of Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 73.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,426 shares of the company's stock after selling 43,235 shares during the period. HighTower Advisors LLC's holdings in Celsius were worth $478,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in CELH. Massachusetts Financial Services Co. MA raised its stake in Celsius by 231.2% during the second quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company's stock valued at $225,289,000 after purchasing an additional 2,754,722 shares in the last quarter. Bank of New York Mellon Corp increased its position in Celsius by 36.7% during the second quarter. Bank of New York Mellon Corp now owns 2,942,433 shares of the company's stock valued at $167,983,000 after acquiring an additional 790,014 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Celsius by 19.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,381,279 shares of the company's stock worth $43,317,000 after purchasing an additional 221,833 shares during the period. Dimensional Fund Advisors LP lifted its stake in Celsius by 86.9% in the second quarter. Dimensional Fund Advisors LP now owns 990,135 shares of the company's stock worth $56,531,000 after purchasing an additional 460,227 shares during the last quarter. Finally, MIG Capital LLC bought a new stake in shares of Celsius during the 3rd quarter worth approximately $30,358,000. 60.95% of the stock is currently owned by institutional investors.
Celsius Price Performance
Shares of CELH stock opened at $27.01 on Friday. Celsius Holdings, Inc. has a 12 month low of $25.23 and a 12 month high of $99.62. The company has a market capitalization of $6.35 billion, a PE ratio of 37.51, a price-to-earnings-growth ratio of 3.44 and a beta of 1.76. The firm's 50-day moving average is $29.78 and its two-hundred day moving average is $39.96.
Analyst Upgrades and Downgrades
Several brokerages have weighed in on CELH. Morgan Stanley lowered their target price on Celsius from $46.00 to $42.00 and set an "equal weight" rating for the company in a report on Wednesday. Piper Sandler lowered their price target on shares of Celsius from $50.00 to $47.00 and set an "overweight" rating for the company in a research report on Tuesday, September 24th. Roth Mkm cut their price objective on shares of Celsius from $40.00 to $38.00 and set a "buy" rating on the stock in a report on Monday, December 16th. Truist Financial upped their target price on Celsius from $30.00 to $35.00 and gave the stock a "hold" rating in a report on Wednesday, October 16th. Finally, JPMorgan Chase & Co. initiated coverage on Celsius in a research report on Thursday, December 12th. They issued an "overweight" rating and a $37.00 price target for the company. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, Celsius presently has an average rating of "Moderate Buy" and an average target price of $50.28.
Check Out Our Latest Stock Report on Celsius
Insider Activity
In other Celsius news, major shareholder William H. Milmoe sold 65,000 shares of the business's stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $31.15, for a total transaction of $2,024,750.00. Following the sale, the insider now directly owns 261,245 shares in the company, valued at $8,137,781.75. This represents a 19.92 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.20% of the company's stock.
About Celsius
(
Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories
Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.